PMID: 28500210May 14, 2017Paper

First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario

Canadian Family Physician Médecin De Famille Canadien
Sheryl SpithoffSamantha Singh

Abstract

To examine use of first-line alcohol use disorder (AUD) medications (naltrexone and acamprosate) among public drug plan beneficiaries in the year following an AUD diagnosis. Retrospective population-based cohort study. Ontario. Individuals eligible for public drug plan benefits who had an AUD diagnosis at a hospital visit between April 1, 2011, and March 31, 2012. Number of AUD medications dispensed to public drug plan beneficiaries who had a recent hospital visit with an AUD diagnosis, and number of prescriptions dispensed per person. A total of 10 394 Ontarians between 18 and 65 years of age were identified who had a hospital visit with an AUD diagnosis and were eligible for public drug plan benefits. The rate of AUD medications dispensed in the subsequent year was 3.56 per 1000 population (95% CI 2.51 to 4.91; n = 37). This rate did not differ significantly by sex (P = .83). Very few public drug plan beneficiaries are dispensed first-line AUD medications in the year following an AUD diagnosis.

Related Concepts

Related Feeds

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Related Papers

Canadian Respiratory Journal : Journal of the Canadian Thoracic Society
Haris M VaidTara Gomes
The Journal of Rheumatology
Donald A RedelmeierRobert J Tibshirani
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
Lisa DolovichSuzanne M Cadarette
© 2022 Meta ULC. All rights reserved